Use of prescription contraceptive methods in the UK general population: A primary care study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 121, Issue 1, 2014, Pages 53-61

  Cea Soriano, L ^a   Garcia Rodriguez L A ^a   MacHlitt, A ^b   Wallander, M A ^c,d  

^a Spanish Centre for Pharmacoepidemiologic Research ^*  (Spain)

^b Bayer HealthCare Pharmaceuticals Inc   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

^d Bayer AB   (Sweden)

Author keywords

Contraceptives; discontinuation; prevalence; switching; The Health Improvement Network; UK

Indexed keywords

CONTRACEPTIVE AGENT; COPPER INTRAUTERINE DEVICE; GESTAGEN; ORAL CONTRACEPTIVE AGENT; LEVONORGESTREL;

ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CONTRACEPTIVE BEHAVIOR; CONTRACEPTIVE PATCH; FEMALE; HUMAN; INCIDENCE; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MAJOR CLINICAL STUDY; MIDDLE AGED; OBSERVATIONAL STUDY; POPULATION; PREGNANCY; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCHOOL CHILD; UNITED KINGDOM; YOUNG ADULT; FOLLOW UP; INTRAUTERINE CONTRACEPTIVE DEVICE; MEDICAL PRACTICE; NOTE; PATIENT PREFERENCE; PREGNANCY TEST; RETROSPECTIVE STUDY; SYSTEMATIC REVIEW (TOPIC);

EID: 84891015495     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12465     Document Type: Article

References (24)

1. Grimes DA,. Forgettable contraception. Contraception 2009; 80: 497-9.
2. Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, et al. Effectiveness of long-acting reversible contraception. N Engl J Med 2012; 366: 1998-2007.
3. Trussell J, Wynn LL,. Reducing unintended pregnancy in the United States. Contraception 2008; 77: 1-5.
4. NICE Guidelines Long Acting Reversible Contraception. 2005 [www.nice.org.uk/nicemedia/live/10974/29912/29912.pdf.]. Last accessed 9 January 2013.
5. Westhoff CL, Heartwell S, Edwards S, Zieman M, Stuart G, Cwiak C, et al. Oral contraceptive discontinuation: do side effects matter? Am J Obstet Gynecol 2007; 196: 412.e1-e6.
6. Grady WR, Billy JO, Klepinger DH,. Contraceptive method switching in the United States. Perspect Sex Reprod Health 2002; 34: 135-45.
7. Peipert JF, Zhao Q, Allsworth JE, Petrosky E, Madden T, Eisenberg D, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol 2011; 117: 1105-13.
8. Rosenberg MJ, Waugh MS,. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 1998; 179: 577-82.
9. Oddens BJ, Visser AP, Vemer HM, Everaerd WT, Lehert P,. Contraceptive use and attitudes in Great Britain. Contraception 1994; 49: 73-86.
10. Torres A, Forrest JD,. The costs of contraception. Fam Plann Perspect 1983; 15: 70-2.
11. Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL,. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007; 16: 393-401.
12. Stuart-Buttle CD, Read JD, Sanderson HF, Sutton YM,. A language of health in action: read Codes, classifications and groupings. Proc AMIA Annu Fall Symp 1996; 75-9.
13. MULTILEX 2012 [www.fdbhealth.co.uk/solutions/multilex/]. Last acc-essed 9 January 9 2013.
14. Opinion Survey Report No. 41 Contraception and Sexual Health, 2008/09 2009 [www.ons.gov.uk/ons/search/index.html?&newquery= Contraception+and+Sexual++Health+Report&pageSize=100&applyFilters= true&sortBy=content-type&sortDirection=ASCENDING.]. Last accessed 9 January 2013.
15. French RS, Mercer CH, Johnson AM, Fenton KA, Erens B, Wellings K,. Use of contraceptive services in Britain: findings from the second National Survey of Sexual Attitudes and Lifestyles (Natsal-2). J Fam Plann Reprod Health Care 2009; 35: 9-14.
16. Skouby SO,. Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries. Eur J Contracept Reprod Health Care 2010; 15 (Suppl 2): S42-53.
17. Mosher WD, Jones J,. Use of contraception in the United States: 1982-2008. Vital Health Stat 2010; 23: 1-44.
18. Wang C,. Trends in contraceptive use and determinants of choice in China: 1980-2010. Contraception 2012; 85: 570-9.
19. Stubbs E, Schamp A,. The evidence is in. Why are IUDs still out?: family physicians' perceptions of risk and indications. Can Fam Physician 2008; 54: 560-6.
20. Kooiker CH, Scutchfield FD,. Barriers to prescribing the Copper T 380A intrauterine device by physicians. West J Med 1990; 153: 279-82.
21. Yuzpe AA,. Oral contraception: trends over time. J Reprod Med 2002; 47: 967-73.
22. Selected practice recommendations for contraceptive use. Available at: [whqlibdoc.who.int/publications/2004/9241562846.pdf]. last accessed 9 January 2013.
23. Pittman ME, Secura GM, Allsworth JE, Homco JB, Madden T, Peipert JF,. Understanding prescription adherence: pharmacy claims data from the Contraceptive CHOICE Project. Contraception 2011; 83: 340-5.
24. First prescription of combined oral contraception. 2007 [www.fsrh.org/pdfs/FirstPrescCombOralContJan06.pdf.]. Last accessed 9 January 2013.